331 related articles for article (PubMed ID: 38399237)
1. Improving the Efficacy of Common Cancer Treatments via Targeted Therapeutics towards the Tumour and Its Microenvironment.
Cecchi D; Jackson N; Beckham W; Chithrani DB
Pharmaceutics; 2024 Jan; 16(2):. PubMed ID: 38399237
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Exploring hypoxic biology to improve radiotherapy outcomes.
Li C; Wiseman L; Okoh E; Lind M; Roy R; Beavis AW; Pires IM
Expert Rev Mol Med; 2022 Apr; 24():e21. PubMed ID: 35586915
[TBL] [Abstract][Full Text] [Related]
4. Exploring novel strategies to improve anti-tumour efficiency: The potential for targeting reactive oxygen species.
Chasara RS; Ajayi TO; Leshilo DM; Poka MS; Witika BA
Heliyon; 2023 Sep; 9(9):e19896. PubMed ID: 37809420
[TBL] [Abstract][Full Text] [Related]
5. Targeted and Non-Targeted Mechanisms for Killing Hypoxic Tumour Cells-Are There New Avenues for Treatment?
Apilan AG; Mothersill C
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445354
[TBL] [Abstract][Full Text] [Related]
6. Improving the synergistic combination of programmed death-1/programmed death ligand-1 blockade and radiotherapy by targeting the hypoxic tumour microenvironment.
Mudassar F; Shen H; Cook KM; Hau E
J Med Imaging Radiat Oncol; 2022 Jun; 66(4):560-574. PubMed ID: 35466515
[TBL] [Abstract][Full Text] [Related]
7. Augmenting the therapeutic window of radiotherapy: A perspective on molecularly targeted therapies and nanomaterials.
Reda M; Bagley AF; Zaidan HY; Yantasee W
Radiother Oncol; 2020 Sep; 150():225-235. PubMed ID: 32598976
[TBL] [Abstract][Full Text] [Related]
8. Advances in Gold Nanoparticle-Based Combined Cancer Therapy.
Bromma K; Chithrani DB
Nanomaterials (Basel); 2020 Aug; 10(9):. PubMed ID: 32858957
[TBL] [Abstract][Full Text] [Related]
9. Adenosine Conjugated Docetaxel Nanoparticles-Proof of Concept Studies for Non-Small Cell Lung Cancer.
Aldawsari HM; Singh S; Alhakamy NA; Bakhaidar RB; Halwani AA; Sreeharsha N; Badr-Eldin SM
Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631370
[TBL] [Abstract][Full Text] [Related]
10. Recent Developments in the Study of the Microenvironment of Cancer and Drug Delivery.
Chaudhary B; Kumar P; Arya P; Singla D; Kumar V; Kumar D; S R; Wadhwa S; Gulati M; Singh SK; Dua K; Gupta G; Gupta MM
Curr Drug Metab; 2023 Jan; ():. PubMed ID: 36627789
[TBL] [Abstract][Full Text] [Related]
11. Hyperbaric oxygenation for tumour sensitisation to radiotherapy.
Bennett MH; Feldmeier J; Smee R; Milross C
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD005007. PubMed ID: 29637538
[TBL] [Abstract][Full Text] [Related]
12. Targeted nanomedicine modalities for prostate cancer treatment.
Cohen L; Livney YD; Assaraf YG
Drug Resist Updat; 2021 May; 56():100762. PubMed ID: 33857756
[TBL] [Abstract][Full Text] [Related]
13. Clostridial spores for cancer therapy: targeting solid tumour microenvironment.
Umer B; Good D; Anné J; Duan W; Wei MQ
J Toxicol; 2012; 2012():862764. PubMed ID: 22737166
[TBL] [Abstract][Full Text] [Related]
14. Gold nanoparticle mediated radiation response among key cell components of the tumour microenvironment for the advancement of cancer nanotechnology.
Bromma K; Cicon L; Beckham W; Chithrani DB
Sci Rep; 2020 Jul; 10(1):12096. PubMed ID: 32694592
[TBL] [Abstract][Full Text] [Related]
15. Targeting cancer with phosphodiesterase inhibitors.
Savai R; Pullamsetti SS; Banat GA; Weissmann N; Ghofrani HA; Grimminger F; Schermuly RT
Expert Opin Investig Drugs; 2010 Jan; 19(1):117-31. PubMed ID: 20001559
[TBL] [Abstract][Full Text] [Related]
16. Emerging Trends in Nano-Driven Immunotherapy for Treatment of Cancer.
Kandasamy G; Karuppasamy Y; Krishnan UM
Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851335
[TBL] [Abstract][Full Text] [Related]
17. Combinatorial therapy in tumor microenvironment: Where do we stand?
Kumari S; Advani D; Sharma S; Ambasta RK; Kumar P
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188585. PubMed ID: 34224836
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenesis in cancer therapeutics: the magic bullet.
Oguntade AS; Al-Amodi F; Alrumayh A; Alobaida M; Bwalya M
J Egypt Natl Canc Inst; 2021 Jul; 33(1):15. PubMed ID: 34212275
[TBL] [Abstract][Full Text] [Related]
19. Enhanced nanoparticle delivery exploiting tumour-responsive formulations.
Bennie LA; McCarthy HO; Coulter JA
Cancer Nanotechnol; 2018; 9(1):10. PubMed ID: 30595759
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
